Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1245701.RARrgV7aIeAorIIhuIjTIQ1lFZ9WH4j-nTY29-obksEWk130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245701.RARrgV7aIeAorIIhuIjTIQ1lFZ9WH4j-nTY29-obksEWk130_provenance.
• NP1245704.RAZ7VDLY1QI8UO8ZZdB4YPObvg0iAvjEYUX2hvw7Eyh0I130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245704.RAZ7VDLY1QI8UO8ZZdB4YPObvg0iAvjEYUX2hvw7Eyh0I130_provenance.
• NP1245702.RAK3aM3bHxoY-ytzZWIxdoxGnJQ8dEeAB3qajIZqXip-k130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245702.RAK3aM3bHxoY-ytzZWIxdoxGnJQ8dEeAB3qajIZqXip-k130_provenance.
• NP1245703.RAHM_uXe-FnS7RGc9ns90cJkuJanPiO3DH6OtbNUoRcCw130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245703.RAHM_uXe-FnS7RGc9ns90cJkuJanPiO3DH6OtbNUoRcCw130_provenance.
• NP1245698.RA0Q-I18_IdHINCde3RoLzbEU6FLu05LO_I6-ln6Z_Zwg130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245698.RA0Q-I18_IdHINCde3RoLzbEU6FLu05LO_I6-ln6Z_Zwg130_provenance.
• NP1245699.RAwCQQH8vJy65vgaKvtQ08DNc_d0UCno4m9qUpcGrAtxc130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245699.RAwCQQH8vJy65vgaKvtQ08DNc_d0UCno4m9qUpcGrAtxc130_provenance.
• NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_assertion description "[In conclusion, the results presented here suggest that Mad2 and BubR1 could be used as prognostic markers of tumor progression and new pharmacological targets in the treatment for GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245700.RAxZVVWjLjwt8Fg2oviru3oKjKF8yEaBcWrVjw-KxpPG8130_provenance.